Table 3.
ROC analysis of C14:1 ratios to specific acylcarnitines and C0 in dried blood specimens of newborns.
| Characteristic | Acylcarnitine Ratios | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C14:1/ C18:1 |
C14:1/ C18 |
C14:1/ C16 |
C14:1/ C16-OH |
C14:1/ C14 |
C14:1/ C12 |
C14:1/ C10 |
C14:1/ C8 |
C14:1/ C6 |
C14:1/ C4 |
C14:1/ C3 |
C14:1/ C2 |
C14:1/ C0 |
|
| Optimal cutoff | 0.319 | 0.600 | 0.153 | 19.444 | 1.398 | 1.264 | 1.905 | 3.725 | 8.828 | 1.959 | 0.394 | 0.023 | 0.025 |
| Sensitivity | 0.788 | 0.634 | 0.915 | 0.926 | 0.709 | 0.941 | 0.978 | 0.989 | 0.986 | 0.914 | 0.559 | 0.895 | 0.696 |
| Specificity | 0.949 | 0.854 | 0.976 | 1.000 | 0.805 | 0.902 | 1.000 | 1.000 | 1.000 | 0.892 | 0.951 | 0.951 | 0.610 |
| Area under the ROC curve |
0.919 | 0.797 | 0.972 | 0.991 | 0.814 | 0.972 | 0.992 | 0.999 | 0.997 | 0.942 | 0.768 | 0.978 | 0.694 |